Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02007044
Title Ibrutinib With or Without Rituximab in Treating Patients With Relapsed Chronic Lymphocytic Leukemia
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors M.D. Anderson Cancer Center
Indications

prolymphocytic leukemia

chronic lymphocytic leukemia/small lymphocytic lymphoma

Therapies

Ibrutinib

Ibrutinib + Rituximab

Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST